ArthroCare unlikely to attract competing bid, NY Times columnist says After British medical technology company Smith & Nephew (SNN) yesterday agreed to buy sports medicine specialist ArthroCare (ARTC) for $1.5B, New York Times columnist Quentin Webb doesn't expect ArthroCare to attract another bid. Smith & Nephew has more synergies with ArthroCare than other potential bidders, making a competing bid unlikely, the columnist explained. Reference Link
News For ARTC;SNN From The Last 14 Days
Check below for free stories on ARTC;SNN the last two weeks.